# Hour 10: 10:00-10:59 - Mid-Morning Steady High Volume

Released on 1 May 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary

Mid-morning steady high volume continues. 6 new arrivals; 2 departures.
PAT-CONT-0036A HCC ablation completes early in hour.

## Cross-Site Status at 10:00 UTC
| Site | On-site | Active | Standby |
|------|---------|--------|---------|
| SITE-A | 18 | 1 | 27 |
| SITE-B | 12 | 0 | 29 |
| SITE-C | 8 | 0 | 29 |
| SITE-D | 7 | 0 | 29 |

## New Arrivals
| ID | Site | Time | Cancer | Robot |
|----|------|------|--------|-------|
| PAT-CONT-0040A | SITE-B | 10:06 | NSCLC RT | RT (3+7) |
| PAT-CONT-0041A | SITE-A | 10:14 | Sarcoma BX | Cobot |
| PAT-CONT-0042A | SITE-D | 10:22 | Pediatric osteo rehab | Rehab |
| PAT-CONT-0043A | SITE-C | 10:30 | LS-SCLC RT | RT (3+7) |
| PAT-CONT-0044A | SITE-A | 10:41 | Liver imaging | Imaging |
| PAT-CONT-0045A | SITE-B | 10:52 | Mantle cell C2D8 IND | Humanoid |

## Activity Log
```
10:00 FDA recon 6/6 ack from hour 09.
10:00-10:08 STEER-01 SITE-A HCC ablation completion (PAT-0036A).
10:09 endpoint TRAVERSE-CONT-0036A-ABL01-COMPLETE ack 11s.
10:06-10:30 RTPOS+TRACK SITE-B NSCLC RT (PAT-0040A).
10:14-10:28 COBOT-02 SITE-A sarcoma biopsy (PAT-0041A).
10:22-10:45 REHAB-01 SITE-D pediatric (PAT-0042A).
10:28 BX endpoint TRAVERSE-CONT-0041A-BX01 ack 11s.
10:30 RT endpoint TRAVERSE-CONT-0040A-RT09 ack 10s.
10:30-10:55 RTPOS+TRACK SITE-C SCLC RT (PAT-0043A).
10:41-10:58 IMAGE-04 SITE-A liver imaging (PAT-0044A).
10:45 REHAB endpoint PED-CONT-0042A-REHAB ack 12s.
10:52-10:59+ HUMAN-01 SITE-B IND C2D8 prep (PAT-0045A).
10:55 RT endpoint STREAM-CONT-0043A-RT01 ack 10s.
10:58 IMG endpoint TRAVERSE-CONT-0044A-IMG ack 12s.
```

## Departures
- PAT-CONT-0011A 10:25 (post-RT 5h obs).
- PAT-CONT-0012A 10:50 (post-biopsy 5h obs).

## Adverse Events
None.

## IND
PAT-CONT-0045A C2D8 prep, infusion begins hour 11.

## Utilization
SITE-A 51 min, SITE-B 56 min, SITE-C 25 min, SITE-D 23 min.
Network util 2.23%.

## RTCT Stream
6 endpoints; median 11.0 s.
